Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.12817
Abstract: Increased hepatic fat and cardiac fat are common in patients with type 2 diabetes mellitus (T2DM) and are associated with a greater risk of liver fibrosis and cardiovascular (CV) events. Sex‐specific differences of dipeptidyl peptidase‐four… read more here.
Keywords: reduces hepatic; fat; gliptin therapy; hepatic myocardial ... See more keywords
Inhaled therapy reduces COPD mortality
Sign Up to like & getrecommendations! Published in 2020 at "ERJ Open Research"
DOI: 10.1183/23120541.00634-2020
Abstract: The Global Initiative for Chronic Obstructive Lung Disease noted a lack of convincing evidence for a survival benefit with inhaled therapy in COPD despite relevant improvements in lung function, exacerbations and patient reported outcomes. Interestingly,… read more here.
Keywords: mortality; triple therapy; therapy; reduces copd ... See more keywords